Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors

被引:0
|
作者
Pankaj Dwivedi
David E. Muench
Michael Wagner
Mohammad Azam
H. Leighton Grimes
Kenneth D. Greis
机构
[1] University of Cincinnati,Department of Cancer Biology
[2] Cincinnati Children’s Hospital Medical Center,Division of Immunobiology and Center for Systems Immunology
[3] Cincinnati Children’s Hospital Medical Center,Division of Biomedical Informatics
[4] Cincinnati Children’s Hospital Medical Center,Division of Experimental Hematology and Cancer Biology
来源
Scientific Data | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Granulocyte colony stimulating factor receptor (G-CSFR) plays an important role in the production of neutrophil granulocytes. Mutated G-CSFRs have been directly associated with two distinct malignant phenotypes in patients, e.g. acute myeloid leukemia (AML) and chronic neutrophilic leukemia (CNL). However, the signaling mechanism of the mutated G-CSFRs is not well understood. Here, we present a comprehensive SILAC-based quantitative phosphoserine and phosphothreonine dataset of the normal and mutated G-CSFRs signaling using the BaF3 cell-line-based in vitro model system. High pH reversed phase concatenation and Titanium Dioxide Spin Tip column were utilized to increase the dynamic range and detection of the phosphoproteome of G-CSFRs. The dataset was further analyzed using several computational tools to validate the quality of the dataset. Overall, this dataset is the first global phosphoproteomics analysis of both normal and disease-associated-mutant G-CSFRs. We anticipate that this dataset will have a strong potential to decipher the phospho-signaling differences between the normal and malignant G-CSFR biology with therapeutic implications. The phosphoproteomic dataset is available via the PRIDE partner repository.
引用
收藏
相关论文
共 50 条
  • [21] Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
    Anderlini, P
    Przepiorka, D
    Champlin, R
    Korbling, M
    BLOOD, 1996, 88 (08) : 2819 - 2825
  • [22] EFFECTS OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR AND GRANULOCYTE COLONY STIMULATING FACTOR IN PATIENT WITH SEVERE CONGENITAL NEUROPENIA (SCN)
    POJDA, Z
    MACHAJ, E
    GESICKAWOZNIAKOWSKA, T
    SOBICZEWSKA, E
    GRZEGORCZYK, W
    WREMBELWARGOCKA, K
    ZEMAN, K
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 777 - 777
  • [23] Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia
    Matsubara, K
    Ochi, H
    Kitagawa, H
    Yamanaka, K
    Kusanagi, Y
    Ito, M
    HYPERTENSION IN PREGNANCY, 1999, 18 (01) : 95 - 106
  • [24] Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor
    Adkins, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 812 - 813
  • [25] A Bayesian meta-analysis of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in children with cancer
    Sung, L
    Beyene, J
    Hayden, J
    Nathan, PC
    Lange, B
    Tomlinson, GA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (09) : 811 - 817
  • [26] Granulocyte colony-stimulating factor and leukemogenesis
    de Figueiredo, LL
    Lima, RSDE
    Rego, EM
    MEDIATORS OF INFLAMMATION, 2004, 13 (03) : 145 - 150
  • [27] Granulocyte colony-stimulating factor and hypercoagulability
    Kaptan, Kuersat
    Beyan, Cengiz
    Ifran, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 131 (01) : 129 - 129
  • [28] ROLE OF GRANULOCYTE COLONY STIMULATING FACTOR IN RADIOTHERAPY
    ZACHARIAH, B
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 304 (04): : 252 - 253
  • [29] THE AVAILABILITY OF GRANULOCYTE-COLONY-STIMULATING FACTOR
    BLACK, P
    NEW ZEALAND MEDICAL JOURNAL, 1994, 107 (976) : 161 - 162
  • [30] IMPURITIES IN GRANULOCYTE-COLONY-STIMULATING FACTOR
    BROWN, S
    ARMSTRONG, M
    ARCHIVES OF DERMATOLOGY, 1994, 130 (06) : 799 - 799